Wycombe Hospital is located in High Wycombe, Buckinghamshire. It is one of two acute and five community hospitals managed by the Buckinghamshire Healthcare NHS Trust.

During the past decade, Wycombe General Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wycombe General Hospital" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Buckinghamshire Healthcare NHS Trust" with 3 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Institute of Cancer Research, United Kingdom" with 3 trials sponsored and "University College, London" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wycombe General Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Animas Corporation" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Basildon and Thurrock Hospitals NHS FoundationTrust" with 1 trials as a collaborator and "Baxter Healthcare Corporation" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Wycombe General Hospital" are "Breast Cancer" (4 trials), "Atherosclerotic Cardiovascular Disease" (3 trials), "Colorectal Cancer" (3 trials), "Heart Failure" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Wycombe General Hospital" in a lesser frequency.

Most popular intervention types in "Wycombe General Hospital" are "Drug" (25 trials), "Procedure" (8 trials), "Other" (6 trials), "Biological" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Filgotinib" (4 trials), "fludarabine phosphate" (3 trials), "quality-of-life assessment" (3 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wycombe General Hospital" are 30 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wycombe General Hospital". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Wycombe General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wycombe General Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".